Last reviewed · How we verify
NCT03534362
Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out
NA trial testing Nasopore in Stent in 1 participant. Terminated before completion.
23 September 2019
Quick facts
| Lead sponsor | St. Louis University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1 |
| Start date | 13 April 2018 |
| Primary completion | 23 September 2019 |
| Estimated completion | 23 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nasopore
- Propel
Conditions studied
- Stent — all drugs for Stent →
- Sinusitis, Frontal — all drugs for Sinusitis, Frontal →
Sponsor
St. Louis University
Who can join
Adults 18 to 90, any sex, with Stent or Sinusitis, Frontal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Surgery on the frontal sinus is done for patients who have sinus problems that do not respond to medications. It involves making an opening within the right and left frontal sinus of the nose to help it drain. For severe frontal sinus disease, the sinus is widely opened and the left and right sinuses become one large sinus. This is done with sharp instruments and rigid endoscopes placed through the nostrils. While the sinus heals after surgery, a stent or steroids or both may be used to try to help make sure that the opening does not close back up. Two current options for this are Propel stents and steroid-soaked Nasopore. Propel stents are FDA-approved. Nasopore and Kenalog injection are both FDA-approved, but their use together is part of the study and not specifically FDA-approved. A previous study shows that Propel stents are useful to reduce scarring in other frontal sinus procedures. We would like to know whether this is true in larger frontal sinus surgery where one common cavity is made and whether both steroid-containing stents are the same.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03534362
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nasopore
Trials testing the same drug.
- NCT03068728 — Analysis of Hemostatic Agents Compared to Physiologic Hemostasis · NA · completed
Other recruiting trials for Stent
Currently open trials in the same condition.
- NCT05972070 — Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence · recruiting
- NCT05340361 — Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT · recruiting
- NCT05202314 — Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer · NA · recruiting
Other St. Louis University trials
Trials by the same sponsor.
- NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
- NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease · NA · recruiting
- NCT04158037 — Don't Go There: A Geospatial mHealth App for Gambling Disorder · NA · withdrawn
- NCT05406310 — Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablatio · withdrawn
- NCT05854836 — Preconception Intervention for Incarcerated Women With Substance Use · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03534362 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Louis University
- Last refreshed: 21 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03534362.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing